Marisa Actis

554 total citations
7 papers, 136 citations indexed

About

Marisa Actis is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Marisa Actis has authored 7 papers receiving a total of 136 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Hematology. Recurrent topics in Marisa Actis's work include Protein Degradation and Inhibitors (6 papers), Ubiquitin and proteasome pathways (4 papers) and CAR-T cell therapy research (3 papers). Marisa Actis is often cited by papers focused on Protein Degradation and Inhibitors (6 papers), Ubiquitin and proteasome pathways (4 papers) and CAR-T cell therapy research (3 papers). Marisa Actis collaborates with scholars based in United States. Marisa Actis's co-authors include Zoran Ranković, Shilpa Narina, Gisele Nishiguchi, Shondra M. Pruett‐Miller, Jamie Jarusiewicz, Jaeki Min, Junmin Peng, Anand Mayasundari, Satoshi Yoshimura and Lei Yang and has published in prestigious journals such as Blood, Journal of Medicinal Chemistry and Cell Death and Differentiation.

In The Last Decade

Marisa Actis

7 papers receiving 131 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marisa Actis United States	5	99	44	40	10	10	7	136
Bonnie Le United States	3	124 1.3×	35 0.8×	40 1.0×	4 0.4×	12 1.2×	4	157
Konstanze Doehner Germany	4	68 0.7×	18 0.4×	41 1.0×	3 0.3×	9 0.9×	14	101
Julius Gräsel Australia	3	107 1.1×	21 0.5×	50 1.3×	2 0.2×	8 0.8×	3	126
Malika Kapadia United States	7	81 0.8×	29 0.7×	49 1.2×	3 0.3×	52 5.2×	14	152
Satyajit Rajapurkar United States	4	149 1.5×	11 0.3×	35 0.9×	9 0.9×	7 0.7×	4	188
Meng Han China	5	73 0.7×	38 0.9×	9 0.2×	4 0.4×	7 0.7×	8	121
Maria Cielo Foudray United States	4	85 0.9×	40 0.9×	53 1.3×	1 0.1×	5 0.5×	6	136
Marjan Mojtabavi Naeini Iran	9	140 1.4×	49 1.1×	10 0.3×	8 0.8×	14 1.4×	12	210
Emil Hermansen Denmark	5	94 0.9×	36 0.8×	71 1.8×	2 0.2×	6 0.6×	13	122
Olena O Shevchuk Canada	3	51 0.5×	19 0.4×	30 0.8×	2 0.2×	32 3.2×	5	92

Countries citing papers authored by Marisa Actis

Since Specialization

Citations

This map shows the geographic impact of Marisa Actis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marisa Actis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marisa Actis more than expected).

Fields of papers citing papers by Marisa Actis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marisa Actis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marisa Actis. The network helps show where Marisa Actis may publish in the future.

Co-authorship network of co-authors of Marisa Actis

This figure shows the co-authorship network connecting the top 25 collaborators of Marisa Actis. A scholar is included among the top collaborators of Marisa Actis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marisa Actis. Marisa Actis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Jarusiewicz, Jamie, Satoshi Yoshimura, Marisa Actis, et al.. (2024). Development of an Orally Bioavailable LCK PROTAC Degrader as a Potential Therapeutic Approach to T-Cell Acute Lymphoblastic Leukemia. Journal of Medicinal Chemistry. 67(14). 11868–11884. 3 indexed citations

2.

Jarusiewicz, Jamie, Satoshi Yoshimura, Anand Mayasundari, et al.. (2023). Phenyl Dihydrouracil: An Alternative Cereblon Binder for PROTAC Design. ACS Medicinal Chemistry Letters. 14(2). 141–145. 44 indexed citations

3.

Li, Yao, et al.. (2023). Design of Class I/IV Bromodomain-Targeting Degraders for Chromatin Remodeling Complexes. ACS Chemical Biology. 18(6). 1278–1293. 4 indexed citations

4.

Quarato, Giovanni, Fabien Llambi, Cliff Guy, et al.. (2022). Ca2+-mediated mitochondrial inner membrane permeabilization induces cell death independently of Bax and Bak. Cell Death and Differentiation. 29(7). 1318–1334. 38 indexed citations

5.

Chang, Yunchao, Jamie Jarusiewicz, Marisa Actis, et al.. (2022). Development of Potent and Selective Janus Kinase 2/3 Directing PG–PROTACs. ACS Medicinal Chemistry Letters. 13(3). 475–482. 24 indexed citations

6.

Jarusiewicz, Jamie, Guoqing Du, Gisele Nishiguchi, et al.. (2022). Preclinical evaluation of proteolytic targeting of LCK as a therapeutic approach in T cell acute lymphoblastic leukemia. Science Translational Medicine. 14(659). eabo5228–eabo5228. 22 indexed citations

7.

Jarusiewicz, Jamie, Jaeki Min, Lei Yang, et al.. (2021). Development of Proteolytic Targeting Chimeras to Target Lck in T-Cell Acute Lymphoblastic Leukemia. Blood. 138(Supplement 1). 867–867. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact